United States · FDA National Drug Code directory
Ranitidine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62207-773_44f2b222-ae43-eef4-e063-6394a90ab2b6
- Product NDC
- 62207-773
- Form
- TABLET
- Composition / generic term
- Ranitidine
- Labeler
- Granules India Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190626
- Source listing expiry
- 20261231
Source-listed ingredients
- RANITIDINE HYDROCHLORIDE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 5 BAG in 1 CARTON (62207-773-36) / 10000 TABLET in 1 BAG (62207-773-32) · 62207-773-36
- 1 BOTTLE in 1 CARTON (62207-773-41) / 24 TABLET in 1 BOTTLE · 62207-773-41
- 1 BOTTLE in 1 CARTON (62207-773-47) / 500 TABLET in 1 BOTTLE · 62207-773-47
- 2 BLISTER PACK in 1 CARTON (62207-773-58) / 10 TABLET in 1 BLISTER PACK · 62207-773-58
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →